Clearance Soon to Pune Firm Which Aims to Provide Oxford Vaccine at Rs 1,000

COVID-19 Vaccine India Updates

COVID-19 Vaccine India Updates: The Centre is expediting the process to give clearance to Serum Institute, Pune, which wants to take up the phase 3 trial of the Oxford vaccine before it starts mass-producing the vaccine.

Soon after the Oxford vaccine kindled some hope in the worldwide fights against COVID-19, Serum Institute of India chief executive officer Adar Poonawalla said that the company will apply for permission for phase 3 trials for the Oxford vaccine in India next week and will begin the study soon.


The Centre has said that the clearance process will be expedited and the firm will be provided with every kind of assistance.

The CEO of the firm, Adar Poonawalla, has said in interviews that the mass production of the vaccine will begin next year. The cost of the vaccine will be kept below Rs 1,000. But in all probabilities, the government may buy and provide to the public at a free of cost through immunisation programmes, reports said. The firm is also working for other countries.

Apart from this, the Centre has already started discussions on how to make COVID-19 vaccines, being developed in India, available to all those who need it, Dr VK Paul, Member (Health), NITI Aayog, has said.


Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button